SALIX PHARMACEUTICALS INC's ticker is and the CUSIP is 795435AE6. A total of 61 filers reported holding SALIX PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $12,751,000 | -63.9% | 6,975,000 | -52.2% | 0.03% | -64.0% |
| Q3 2014 | $35,350,000 | -30.1% | 14,585,000 | -43.3% | 0.09% | +53.4% |
| Q2 2014 | $50,608,000 | +323.6% | 25,714,000 | +265.0% | 0.06% | +114.8% |
| Q1 2014 | $11,946,000 | +4.2% | 7,045,000 | -8.1% | 0.03% | +3.8% |
| Q4 2013 | $11,459,000 | +27.9% | 7,662,000 | +5.3% | 0.03% | +23.8% |
| Q3 2013 | $8,962,000 | -1.8% | 7,275,000 | -4.5% | 0.02% | 0.0% |
| Q2 2013 | $9,124,000 | – | 7,615,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TENOR CAPITAL MANAGEMENT Co., L.P. | 36,001,000 | $95,697,000 | 16.53% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 145,320,992 | $386,133,000 | 6.28% |
| Verition Fund Management LLC | 18,500,000 | $49,268,000 | 5.72% |
| PIPER SANDLER & CO. | 3,750,000 | $9,968,000 | 4.14% |
| BERKLEY W R CORP | 25,881,000 | $68,886,000 | 3.58% |
| WOLVERINE ASSET MANAGEMENT LLC | 31,256,000 | $83,048,000 | 1.66% |
| TT INTERNATIONAL | 760,000 | $2,020,000 | 1.41% |
| FARALLON CAPITAL MANAGEMENT LLC | 31,014,000 | $82,372,000 | 1.20% |
| CSS LLC/IL | 8,300,000 | $22,057,000 | 1.12% |
| SG Americas Securities, LLC | 370,000 | $98,536,000 | 0.59% |